In agreement with TCGA data that indicates that 8% of mutated BRAFV600E human melanoma showed the overexpression of the VEGFA transcript, our work suggests that an improvement patient's molecular stratification taking into account the expression of VEGFA, might open new therapeutic regimens based on targeting VEGFA in advanced metastatic melanomas. This evidence concerns the gene VEGFA and melanoma.